Rigel Pharmaceuticals: Q4 Earnings Insights

Rigel Pharmaceuticals RIGL reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.


Rigel Pharmaceuticals beat estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.03.

Revenue was down $15.49 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 2.0% increase in the share price the next day.

Here's a look at Rigel Pharmaceuticals's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.07 -0.08 -0.10 -0.11
EPS Actual -0.03 -0.04 -0.08 0.01
Revenue Estimate 27.20M 26.02M 24.07M 27.97M
Revenue Actual 28.13M 26.89M 26.07M 51.28M

To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!